(Q41095351)

26 September 2017

1 reference

title

5-HT3 receptors: pharmacologic and therapeutic aspects (English)

1 reference

26 September 2017

Gyermek L

1

1 reference

26 September 2017

publication date

1 September 1995

1 reference

The Journal of Clinical Pharmacology

26 September 2017

published in

1 reference

26 September 2017

volume

35

1 reference

26 September 2017

issue

9

1 reference

26 September 2017

page(s)

845-855

1 reference

Neuronal 5-HT receptors in the periphery.

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Distribution of serotonin receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

5-HT3 receptors are membrane ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

The selectivity of the channel coupled to the 5-HT3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

5-HT3 antagonists in postoperative nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

[3H] GR67330, a very high affinity ligand for 5-HT3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

The role of 5-HT in postoperative nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Novel 5-HT3 antagonists. Indole oxadiazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

[3H]zacopride: ligand for the identification of 5-HT3 recognition sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

5-HT3 receptor antagonists. 1. New quinoline derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Neuropharmacology of emesis induced by anti-cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Tropisetron for postoperative nausea and vomiting in patients after gynaecological surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Effects of granisetron and lorazepam, alone and in combination, on psychometric performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Characterization of the novel 5-HT3 antagonists MDL 73147EF (dolasetron mesilate) and MDL 74156 in NG108-15 neuroblastoma x glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

New modalities in postoperative nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Efficacy of orally administered ondansetron in the prevention of postoperative nausea and vomiting: a dose ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Influence of a specific 5-HT3 antagonist on carrageenan-induced hyperalgesia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Reversal of the antinociceptive effects of intrathecally administered serotonin in the rat by a selective 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

First Clinical Study of the Selective 5-HT3 Antagonist, Granisetron (BRL 43694), in the Acute Treatment of Migraine Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

The psychopharmacology of 5-HT3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Zacopride: anxiolytic profile in rodent and primate models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

Interactions between dopamine and 5-HT3 receptors suggest new treatments for psychosis and drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

The concept of selectivity in 5-HT receptor research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

5-Hydroxy-3-indoleacetamidine: a New Type of Blocking Agent against 5-Hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04129.X

10.1002/J.1552-4604.1995.TB04129.X

21 January 2018

Identifiers

DOI

1 reference

26 September 2017

1 reference